Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP527933.RAVhn7_t2nX5C5Vg4B9G3mswnis-sQ9CVnCYBwHufNm50130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP527933.RAVhn7_t2nX5C5Vg4B9G3mswnis-sQ9CVnCYBwHufNm50130_assertion type Assertion NP527933.RAVhn7_t2nX5C5Vg4B9G3mswnis-sQ9CVnCYBwHufNm50130_head.
- NP527933.RAVhn7_t2nX5C5Vg4B9G3mswnis-sQ9CVnCYBwHufNm50130_assertion description "[Furthermore, the reduced RBM5 protein expression correlated with smoking status, tumor stage and lymph node metastasis of NSCLC, while overexpression of EGFR and KRAS proteins correlated with tumor stage and lymph node metastasis of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527933.RAVhn7_t2nX5C5Vg4B9G3mswnis-sQ9CVnCYBwHufNm50130_provenance.
- NP527933.RAVhn7_t2nX5C5Vg4B9G3mswnis-sQ9CVnCYBwHufNm50130_assertion evidence source_evidence_literature NP527933.RAVhn7_t2nX5C5Vg4B9G3mswnis-sQ9CVnCYBwHufNm50130_provenance.
- NP527933.RAVhn7_t2nX5C5Vg4B9G3mswnis-sQ9CVnCYBwHufNm50130_assertion SIO_000772 22537942 NP527933.RAVhn7_t2nX5C5Vg4B9G3mswnis-sQ9CVnCYBwHufNm50130_provenance.
- NP527933.RAVhn7_t2nX5C5Vg4B9G3mswnis-sQ9CVnCYBwHufNm50130_assertion wasDerivedFrom befree-20150227 NP527933.RAVhn7_t2nX5C5Vg4B9G3mswnis-sQ9CVnCYBwHufNm50130_provenance.
- NP527933.RAVhn7_t2nX5C5Vg4B9G3mswnis-sQ9CVnCYBwHufNm50130_assertion wasGeneratedBy ECO_0000203 NP527933.RAVhn7_t2nX5C5Vg4B9G3mswnis-sQ9CVnCYBwHufNm50130_provenance.